A Win For Myovant Sciences Ltd.

Tue 19 Nov 19 at 05:30 PM
A Win For Myovant Sciences Ltd.

Myovant Sciences Ltd. (MYOV:NYSE) soared today at $12.92, representing a gain of 113.2%. On Mon, 18 Nov 19, MYOV:NYSE hit a New 2-Week Intraday High of $6.34. The stock appeared on our News Catalysts scanner on Tue, 19 Nov 19 at 02:26 PM. From Tue, 29 Oct 19, the stock recorded 57.14% Up Days and 60.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About Myovant Sciences Ltd. (MYOV:NYSE)

Myovant Sciences Ltd is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing therapies for women's health diseases and other endocrine-related disorders. Its product candidate is relugolix.

Share